Results 121 to 130 of about 9,438 (207)

Comparing immune-checkpoint inhibitor-mediated inflammatory arthritis to polymyalgia rheumatica: a prospective cohort study. [PDF]

open access: yesJ Immunother Cancer
Tison A   +17 more
europepmc   +1 more source

Lifetime risk of malignancy in polymyalgia rheumatica: a population-based matched cohort study from southern Norway. [PDF]

open access: yesRheumatology (Oxford)
Tengesdal S   +5 more
europepmc   +1 more source

Outcomes of polymyalgia rheumatica

open access: yes, 2019
In this study the outcomes of cases of patients diagnosed with polymyalgia rheumatica and treated in Kaunas Clinics of the Hospital of LUHS during the period of 2011-2015 were analysed. Data about 74 patients was collected from medical documentations and
Zobielienė, Dovilė
core  

Steroid-sparing strategies in polymyalgia rheumatica: a systematic review and meta-analysis of tocilizumab with practical guidance for tapering. [PDF]

open access: yesBMC Rheumatol
Bungish MK   +12 more
europepmc   +1 more source

Whole-body Dynamic [18F]FDG-PET/CT in Giant Cell Arteritis and Polymyalgia Rheumatica. [PDF]

open access: yesClin Nucl Med
Sah BR   +11 more
europepmc   +1 more source

Modern Management of Isolated Polymyalgia Rheumatica. [PDF]

open access: yesRheumatol Ther
Harkins P   +6 more
europepmc   +1 more source

Short-course prednisone and methotrexate in a cohort of patients with polymyalgia rheumatica: a potential therapeutic approach. [PDF]

open access: yesBMC Rheumatol
Conticini E   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy